Regenerex Pharma suspends CFO Kenneth Perry; appoints Don E. Ray as interim CFO

REGENEREX PHARMA, INC.

CFO Kenneth Perry placed on administrative suspension leave with pay, effective March 31, 2026, due to concerns over compliance, financial oversight, governance, and internal controls.
Don E. Ray appointed Interim CFO effective April 1, 2026, for an initial 90-day term at an annual salary of $150,000.
Board reassigned Perry's duties to interim CFO; review of the concerns is ongoing with no final determinations yet.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.